These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. The use of olanzapine for movement disorder in Huntington's disease: a first case report. Dipple HC J Neurol Neurosurg Psychiatry; 1999 Jul; 67(1):123-4. PubMed ID: 10454874 [No Abstract] [Full Text] [Related]
9. Functional and motor response to low dose olanzapine in Huntington's disease: case report. Laks J; Rocha M; Capitão C; Domingues RC; Ladeia G; Lima M; Engelhardt E Arq Neuropsiquiatr; 2004 Dec; 62(4):1092-4. PubMed ID: 15608976 [TBL] [Abstract][Full Text] [Related]
10. Short-term effects of olanzapine in Huntington disease. Squitieri F; Cannella M; Porcellini A; Brusa L; Simonelli M; Ruggieri S Neuropsychiatry Neuropsychol Behav Neurol; 2001 Jan; 14(1):69-72. PubMed ID: 11234911 [TBL] [Abstract][Full Text] [Related]
11. An open-label study of the treatment efficacy of olanzapine for Tourette's disorder. Budman CL; Gayer A; Lesser M; Shi Q; Bruun RD J Clin Psychiatry; 2001 Apr; 62(4):290-4. PubMed ID: 11379844 [TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of valbenazine for the treatment of chorea associated with Huntington's disease (KINECT-HD): a phase 3, randomised, double-blind, placebo-controlled trial. Furr Stimming E; Claassen DO; Kayson E; Goldstein J; Mehanna R; Zhang H; Liang GS; Haubenberger D; Lancet Neurol; 2023 Jun; 22(6):494-504. PubMed ID: 37210099 [TBL] [Abstract][Full Text] [Related]
13. Depressive signs and symptoms in schizophrenia: a prospective blinded trial of olanzapine and haloperidol. Tollefson GD; Sanger TM; Lu Y; Thieme ME Arch Gen Psychiatry; 1998 Mar; 55(3):250-8. PubMed ID: 9510219 [TBL] [Abstract][Full Text] [Related]
14. Olanzapine versus placebo in the treatment of acute mania. Olanzapine HGEH Study Group. Tohen M; Sanger TM; McElroy SL; Tollefson GD; Chengappa KN; Daniel DG; Petty F; Centorrino F; Wang R; Grundy SL; Greaney MG; Jacobs TG; David SR; Toma V Am J Psychiatry; 1999 May; 156(5):702-9. PubMed ID: 10327902 [TBL] [Abstract][Full Text] [Related]
15. A prospective open-label treatment trial of olanzapine monotherapy in children and adolescents with bipolar disorder. Frazier JA; Biederman J; Tohen M; Feldman PD; Jacobs TG; Toma V; Rater MA; Tarazi RA; Kim GS; Garfield SB; Sohma M; Gonzalez-Heydrich J; Risser RC; Nowlin ZM J Child Adolesc Psychopharmacol; 2001; 11(3):239-50. PubMed ID: 11642474 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzipine HGGW Study Group. Tohen M; Jacobs TG; Grundy SL; McElroy SL; Banov MC; Janicak PG; Sanger T; Risser R; Zhang F; Toma V; Francis J; Tollefson GD; Breier A Arch Gen Psychiatry; 2000 Sep; 57(9):841-9. PubMed ID: 10986547 [TBL] [Abstract][Full Text] [Related]
17. Improvement of Huntington's disease with olanzapine and valproate. Grove VE; Quintanilla J; DeVaney GT N Engl J Med; 2000 Sep; 343(13):973-4. PubMed ID: 11012330 [No Abstract] [Full Text] [Related]
18. Evidence for the effectiveness of olanzapine among patients nonresponsive and/or intolerant to risperidone. Dossenbach MR; Kratky P; Schneidman M; Grundy SL; Metcalfe S; Tollefson GD; Belmaker RH J Clin Psychiatry; 2001; 62 Suppl 2():28-34. PubMed ID: 11232749 [TBL] [Abstract][Full Text] [Related]
19. A randomized double-blind study of risperidone and olanzapine in the treatment of schizophrenia or schizoaffective disorder. Conley RR; Mahmoud R Am J Psychiatry; 2001 May; 158(5):765-74. PubMed ID: 11329400 [TBL] [Abstract][Full Text] [Related]
20. Controlled, double-blind investigation of the clozapine discontinuation symptoms with conversion to either olanzapine or placebo. The Collaborative Crossover Study Group. Tollefson GD; Dellva MA; Mattler CA; Kane JM; Wirshing DA; Kinon BJ J Clin Psychopharmacol; 1999 Oct; 19(5):435-43. PubMed ID: 10505585 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]